Organ-on-a-chip platforms for studying drug delivery systems

被引:281
作者
Bhise, Nupura S. [1 ,2 ]
Ribas, Joao [1 ,2 ,3 ,4 ]
Manoharan, Vijayan [1 ,2 ]
Zhang, Yu Shrike [1 ,2 ]
Polini, Alessandro [1 ,2 ]
Massa, Solange [1 ,2 ]
Dokmeci, Mehmet R. [1 ,2 ]
Khademhosseini, Ali [1 ,2 ,5 ,6 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Biomed Engn,Dept Med, Cambridge, MA 02139 USA
[2] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA
[3] Univ Coimbra, Inst Interdisciplinary Res, Ctr Neurosci & Cell Biol, Doctoral Programme Expt Biol & Biomed, P-3030789 Coimbra, Portugal
[4] Biocant Biotechnol Innovat Ctr, P-3060197 Cantanhede, Portugal
[5] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA
[6] King Abdulaziz Univ, Dept Phys, Jeddah 21569, Saudi Arabia
基金
美国国家卫生研究院;
关键词
Organ-on-a-chip; Drug delivery; Nanoparticle; Drug screening; Toxicity; HUMAN-BREAST-CANCER; IN-VITRO MODEL; HUMAN LIVER; CELL-CULTURE; MICROFLUIDIC SYSTEM; MULTICELLULAR SPHEROIDS; NANOPARTICLE UPTAKE; EMBRYOID BODIES; TUMOR SPHEROIDS; QUANTUM DOTS;
D O I
10.1016/j.jconrel.2014.05.004
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
Novel microfluidic tools allow new ways to manufacture and test drug delivery systems. Organ-on-a-chip systems - microscale recapitulations of complex organ functions - promise to improve the drug development pipeline. This review highlights the importance of integrating microfluidic networks with 3D tissue engineered models to create organ-on-a-chip platforms, able to meet the demand of creating robust preclinical screening models. Specific examples are cited to demonstrate the use of these systems for studying the performance of drug delivery vectors and thereby reduce the discrepancies between their performance at preclinical and clinical trials. Wealso highlight the future directions that need to be pursued by the research community for these proof-of-concept studies to achieve the goal of accelerating clinical translation of drug delivery nanoparticles. (C) 2014 Elsevier B. V. All rights reserved.
引用
收藏
页码:82 / 93
页数:12
相关论文
共 150 条
[1]
Microfluidic heart on a chip for higher throughput pharmacological studies [J].
Agarwal, Ashutosh ;
Goss, Josue Adrian ;
Cho, Alexander ;
McCain, Megan Laura ;
Parker, Kevin Kit .
LAB ON A CHIP, 2013, 13 (18) :3599-3608
[2]
Tumour-on-a-chip provides an optical window into nanoparticle tissue transport [J].
Albanese, Alexandre ;
Lam, Alan K. ;
Sykes, Edward A. ;
Rocheleau, Jonathan V. ;
Chan, Warren C. W. .
NATURE COMMUNICATIONS, 2013, 4
[3]
Hydrogel-coated microfluidic channels for cardiomyocyte culture [J].
Annabi, Nasim ;
Selimovic, Seila ;
Acevedo Cox, Juan Pablo ;
Ribas, Joao ;
Bakooshli, Mohsen Afshar ;
Heintze, Deborah ;
Weiss, Anthony S. ;
Cropek, Donald ;
Khademhosseini, Ali .
LAB ON A CHIP, 2013, 13 (18) :3569-3577
[4]
Delivering Nanoparticles to Lungs while Avoiding Liver and Spleen through Adsorption on Red Blood Cells [J].
Anselmo, Aaron C. ;
Gupta, Vivek ;
Zern, Blaine J. ;
Pan, Daniel ;
Zakrewsky, Michael ;
Muzykantov, Vladimir ;
Mitragotri, Samir .
ACS NANO, 2013, 7 (12) :11129-11137
[5]
Arunraj T.R., 2013, COLLOIDS SURF B C, V113C, P394
[6]
Baselga J, 1998, CANCER RES, V58, P2825
[7]
Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer [J].
Batist, G ;
Ramakrishnan, G ;
Rao, CS ;
Chandrasekharan, A ;
Gutheil, J ;
Guthrie, T ;
Shah, P ;
Khojasteh, A ;
Nair, MK ;
Hoelzer, K ;
Tkaczuk, K ;
Park, YC ;
Lee, LW .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) :1444-1454
[8]
Behavior of HepG2/C3A cell cultures in a microfluidic bioreactor [J].
Baudoin, Regis ;
Griscom, Laurent ;
Prot, Jean Matthieu ;
Legallais, Cecile ;
Leclerc, Eric .
BIOCHEMICAL ENGINEERING JOURNAL, 2011, 53 (02) :172-181
[9]
Engineers are from PDMS-land, Biologists are from Polystyrenia [J].
Berthier, Erwin ;
Young, Edmond W. K. ;
Beebe, David .
LAB ON A CHIP, 2012, 12 (07) :1224-1237
[10]
Drug delivery strategies for therapeutic angiogenesis and antiangiogenesis [J].
Bhise, Nupura S. ;
Shmueli, Ron B. ;
Sunshine, Joel C. ;
Tzeng, Stephany Y. ;
Green, Jordan J. .
EXPERT OPINION ON DRUG DELIVERY, 2011, 8 (04) :485-504